Novacyt: Monthly Report on the Liquidity and Voting Rights Contract

Novacyt, a player in the clinical diagnostics sector, has revealed the details of transactions carried out under its liquidity contract for February 2023. During this month, 35,021 shares were acquired at a price ranging from €0.66 to €0.79, while 15,132 shares were sold at prices ranging from €0.68 to €0.83. As of February 28, 2023, the company held 52,502 treasury shares.

In terms of voting rights, Novacyt has a total of 70,626,248 ordinary shares. Shareholders can use this figure to assess their stake in the company. It should be noted that Novacyt is not subject to the transparency rules of the FCA's Financial Services and Markets Act.